Deutsche Bank AG Makes New Investment in DENTSPLY SIRONA Inc. $XRAY

Deutsche Bank AG purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 267,407 shares of the medical instruments supplier’s stock, valued at approximately $2,837,000.

Several other hedge funds also recently modified their holdings of XRAY. Bank of New York Mellon Corp acquired a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at $16,408,000. Focus Partners Advisor Solutions LLC bought a new stake in DENTSPLY SIRONA in the second quarter valued at $251,000. State of Wyoming acquired a new position in shares of DENTSPLY SIRONA during the second quarter valued at about $250,000. GSA Capital Partners LLP bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter worth about $483,000. Finally, Bank of America Corp DE grew its stake in DENTSPLY SIRONA by 18.3% in the first quarter. Bank of America Corp DE now owns 2,432,457 shares of the medical instruments supplier’s stock valued at $28,217,000 after acquiring an additional 375,994 shares during the period. Institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on XRAY. Barclays lifted their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a report on Monday. UBS Group decreased their target price on DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Mizuho decreased their price objective on shares of DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Piper Sandler boosted their target price on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Finally, Barrington Research set a $15.00 target price on shares of DENTSPLY SIRONA in a research report on Monday, August 10th. Three research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $13.54.

Insider Activity

In other news, Director Brian T. Gladden bought 9,985 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was bought at an average cost of $10.02 per share, for a total transaction of $100,049.70. Following the completion of the acquisition, the director owned 61,849 shares in the company, valued at approximately $619,726.98. This trade represents a 19.25% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Brian P. Mckeon acquired 10,000 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was acquired at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the completion of the transaction, the director owned 10,000 shares in the company, valued at approximately $101,200. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders bought 35,160 shares of company stock valued at $351,179. Insiders own 0.46% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $10.93 on Thursday. DENTSPLY SIRONA Inc. has a 52 week low of $9.40 and a 52 week high of $14.86. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48. The company’s fifty day moving average is $12.07 and its 200 day moving average is $11.77. The stock has a market cap of $2.18 billion, a PE ratio of -3.97, a PEG ratio of 1.38 and a beta of 0.85.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The business had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. During the same period last year, the company earned $0.52 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.41 earnings per share for the current year.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.